Federal Register - January 4, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
72
Federal Register / Vol. 86, No. 1 / Monday, January 4, 2021 / Notices
as Affiliates and Collapse Them Into a Single Entity Comment 2: Whether Commerce Should Revise Its CV Profit Calculation Comment 3: Whether Araupels Log Valuations Are Inaccurate and Do Not Reflect an Accurate Market Price Comment 4: Whether Commerce Should Recalculate the Fair Value Adjustment for Araupels Costs for Biological Assets Consumed during the POI
Comment 5: Whether Commerce Incorrectly Decreased Araupels Costs for Biological Assets Not Consumed during the POI
Comment 6: Whether Commerce Should Apply the Major Input Rule to Araupels Log Purchases Comment 7: Whether Unreconciled Costs Should Be Allocated to Production Costs Comment 8: Whether Araupels Non-Prime Merchandise Should Be Assigned Full Production Costs Comment 9: Whether Commerce Should Use the Federal Reserves Small Business Lending Survey Short-Term Interest Rate To Calculate Araupels Credit Expenses Comment 10: Whether Commerce Should Use the Earlier of the Shipment Date or Commercial Invoice as Braslumber/
BrasPines Date of Sale Comment 11: Whether the Date of Sale Should Be Consistent Between the Mandatory Respondents Comment 12: Whether Commerce Should Include Araupels Reported Other Revenue V. Recommendation FR Doc. 202029103 Filed 123120; 8:45 am BILLING CODE 3510DSP
DEPARTMENT OF COMMERCE
International Trade Administration A570937, C570938
Citric Acid and Certain Citrate Salts From the Peoples Republic of China:
Continuation of Antidumping Duty and Countervailing Duty Orders Enforcement and Compliance, International Trade Administration, Department of Commerce.
SUMMARY: As a result of the determinations by the Department of Commerce Commerce and the U.S.
International Trade Commission ITC
that revocation of the antidumping AD
and countervailing duty CVD orders on citric acid and certain citrate salts from the Peoples Republic of China China would likely lead to a continuation or recurrence of dumping, countervailable subsidies, and material injury to an industry in the United States, Commerce is publishing a notice of continuation of the AD and CVD
orders.
AGENCY:
DATES:
Applicable January 4, 2021.
VerDate Sep<11>2014
17:28 Dec 31, 2020
Jkt 253001
Ian Hamilton, AD/CVD Operations, Office II, or Zachary Shaykin, AD/CVD
Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone:
202 4824798 and 202 4822638, respectively.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Background On May 29, 2009, Commerce published in the Federal Register a notice of the AD and CVD orders on citric acid and certain citrate salts from China.1 On May 1, 2020, Commerce initiated,2 and the ITC instituted,3 the second sunset review of the Orders, pursuant to section 751c of the Tariff Act of 1930, as amended the Act.
As a result of its reviews, Commerce determined, pursuant to sections 751c1 and 752c of the Act, that revocation of the Orders would likely lead to continuation or recurrence of dumping and countervailable subsidies.
Commerce therefore notified the ITC of the magnitude of the margins of dumping and subsidy rates likely to prevail should these Orders be revoked.4 On December 21, 2020, the ITC published its determination that revocation of the Orders would likely lead to a continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time, pursuant to sections 751c and 752a of the Act.5
1 See Citric Acid and Certain Citrate Salts from Canada and the Peoples Republic of China:
Antidumping Duty Orders, 74 FR 25703 May 29, 2009; see also Citric Acid and Certain Citrate Salts from the Peoples Republic of China: Notice of Countervailing Duty Order, 74 FR 25705 May 29, 2009 collectively, Orders.
2 See Initiation of Five-Year Sunset Reviews, 85
FR 25386 May 1, 2020.
3 See Citric Acid and Certain Citrate Salts from Canada and China; Institution of Five-Year Reviews, 85 FR 25475 May 1, 2020.
4 See Citric Acid and Certain Citrate Salts from the Peoples Republic of China: Final Results of Second Expedited Sunset Review of Antidumping Duty Order, 85 FR 50009 August 17, 2020, and accompanying Issues and Decision Memorandum;
see also Citric Acid and Certain Citrate Salts from the Peoples Republic of China: Final Results of the Expedited Second Five-Year Sunset Review of the Countervailing Duty Order, 85 FR 54536 September 2, 2020, and accompanying Issues and Decision Memorandum.
5 See Citric Acid and Certain Citrate Salts from China Inv. Nos. 701TA456 and 731TA1152
Second Review, 85 FR 84371 December 28, 2020; see also Citric Acid and Certain Citrate Salts from China Inv. Nos. 701TA456 and 731TA
1152 Second Review, USITC Pub. 5147
December 2020.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Scope of the Orders The scope of the orders includes all grades and granulation sizes of citric acid, sodium citrate, and potassium citrate in their unblended forms, whether dry or in solution, and regardless of packaging type. The scope also includes blends of citric acid, sodium citrate, and potassium citrate; as well as blends with other ingredients, such as sugar, where the unblended forms of citric acid, sodium citrate, and potassium citrate constitute 40
percent or more, by weight, of the blend.
The scope of the order also includes all forms of crude calcium citrate, including dicalcium citrate monohydrate, and tricalcium citrate tetrahydrate, which are intermediate products in the production of citric acid, sodium citrate, and potassium citrate. The scope of the order does not include calcium citrate that satisfies the standards set forth in the United States Pharmacopeia and has been mixed with a functional excipient, such as dextrose or starch, where the excipient constitutes at least 2 percent, by weight, of the product. The scope of the order includes the hydrous and anhydrous forms of citric acid, the dihydrate and anhydrous forms of sodium citrate, otherwise known as citric acid sodium salt, and the monohydrate and monopotassium forms of potassium citrate. Sodium citrate also includes both trisodium citrate and monosodium citrate, which are also known as citric acid trisodium salt and citric acid monosodium salt, respectively. Citric acid and sodium citrate are classifiable under 2918.14.0000 and 2918.15.1000 of the Harmonized Tariff Schedule of the United States HTSUS, respectively.
Potassium citrate and crude calcium citrate are classifiable under 2918.15.5000 and 3824.90.9290 of the HTSUS, respectively. Blends that include citric acid, sodium citrate, and potassium citrate are classifiable under 3824.90.9290 of the HTSUS. Although the HTSUS subheadings are provided for convenience and customs purposes, our written description of the scope is dispositive.
Continuation of the Orders As a result of the determinations by Commerce and the ITC that revocation of the Orders would likely lead to a continuation or recurrence of dumping, countervailable subsidies and material injury to an industry in the United States, pursuant to section 751d2 of the Act and 19 CFR 351.218a, Commerce hereby orders the continuation of the Orders. U.S.
Customs and Border Protection will
E:FRFM04JAN1.SGM
04JAN1